Smokers will soon have a new tool in their battle to kick the habit. The FDA has approved Chantix, a smoking cessation pill that works by targeting the area of the brain that nicotine effects.
The drug provides a small amount of nicotine to help ease withdrawal symptoms, and then it blocks the effect of nicotine if the smoker lights up again. Clinical studies found the drug was far superior to Placebo pills, some studies even found it works better than Zyban, a smoking cessation drug already on the market.
Researchers say the best chance of success on Chantix is to use it for 24 weeks, including weekly visits with a physician or counselor.